Though Altman said he likely wouldn’t agree with Trump on “everything,” the OpenAI CEO said he believes “he will be ...
Sam Altman-backed Retro Biosciences is raising $1 billion to develop drugs that extend human lifespan by 10 years, the FT ...
Sam Altman, the CEO of OpenAI, has announced a shift in his previously critical perspective on President Donald Trump.
It’s the latest clash in a feud between the two tech billionaires that started on OpenAI’s board and is now testing Musk’s ...
OpenAI CEO Sam Altman took the technology world by surprise on Thursday with the release of Operator, his company's first AI ...
OpenAI CEO Sam Altman envisions a future where AI surpasses human intelligence, emphasizing that human skills will still hold ...
The White House broke its days-long silence about SpaceX CEO Elon Musk on Friday, as questions swirled about whether Musk had ...
OpenAI announced that it is launching a research preview of Operator, an AI agent that can take control of a browser and perform tasks.